Your browser doesn't support javascript.
loading
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.
Rollison, Dana E; Komrokji, Rami; Lee, Ji-Hyun; Hampras, Shalaka; Fulp, William; Fisher, Kate; Baz, Rachid; Nishihori, Taiga; Xu, Qiang; Olesnyckyj, Marta; Kenvin, Laurie; Knight, Robert; Sullivan, Daniel; Alsina, Melissa; Dalton, William; Shain, Kenneth H.
Afiliação
  • Rollison DE; a Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.
  • Komrokji R; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
  • Lee JH; c Biostatistics Core, University of New Mexico Cancer Center , Albuquerque , NM , USA.
  • Hampras S; a Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.
  • Fulp W; d Department of Biostatistics , Moffitt Cancer Center , Tampa , FL , USA.
  • Fisher K; d Department of Biostatistics , Moffitt Cancer Center , Tampa , FL , USA.
  • Baz R; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
  • Nishihori T; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
  • Xu Q; e Celgene Corporation , Summit , NJ , USA.
  • Olesnyckyj M; e Celgene Corporation , Summit , NJ , USA.
  • Kenvin L; e Celgene Corporation , Summit , NJ , USA.
  • Knight R; e Celgene Corporation , Summit , NJ , USA.
  • Sullivan D; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
  • Alsina M; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
  • Dalton W; f DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center/M2GEN , Tampa , FL , USA.
  • Shain KH; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
Leuk Lymphoma ; 58(3): 560-568, 2017 03.
Article em En | MEDLINE | ID: mdl-27424609
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Segunda Neoplasia Primária / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Segunda Neoplasia Primária / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article